Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan
· Delayed Price · Currency is JPY 5,615.00
-17.00 (-0.30%)
Mar 10, 2026, 3:24 PM JST
Kobayashi Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 418,676 | 403,511 | 463,131 | 503,841 | 650,295 | 704,427 | Upgrade
|
| Market Cap Growth | -2.64% | -12.87% | -8.08% | -22.52% | -7.69% | -28.53% | Upgrade
|
| Enterprise Value | 348,749 | 346,251 | 412,429 | 409,238 | 545,580 | 602,944 | Upgrade
|
| Last Close Price | 5632.00 | 5428.00 | 6110.34 | 6545.86 | 8584.51 | 8506.77 | Upgrade
|
| PE Ratio | 114.52 | 110.37 | 46.01 | 24.77 | 32.48 | 35.73 | Upgrade
|
| Forward PE | 39.73 | 30.37 | 30.11 | 24.52 | 33.46 | 34.40 | Upgrade
|
| PS Ratio | 2.53 | 2.44 | 2.80 | 2.91 | 3.91 | 4.54 | Upgrade
|
| PB Ratio | 1.98 | 1.91 | 2.17 | 2.46 | 3.29 | 3.60 | Upgrade
|
| P/TBV Ratio | 2.16 | 2.08 | 2.40 | 2.75 | 3.52 | 3.85 | Upgrade
|
| P/FCF Ratio | 33.94 | 32.71 | - | 89.91 | 37.88 | 37.56 | Upgrade
|
| P/OCF Ratio | 16.36 | 15.77 | 41.18 | 27.44 | 20.38 | 31.42 | Upgrade
|
| PEG Ratio | 1.04 | 2.43 | - | 20.43 | 13.39 | 11.08 | Upgrade
|
| EV/Sales Ratio | 2.10 | 2.09 | 2.49 | 2.36 | 3.28 | 3.88 | Upgrade
|
| EV/EBITDA Ratio | 14.78 | 14.68 | 12.60 | 12.92 | 17.12 | 19.59 | Upgrade
|
| EV/EBIT Ratio | 23.49 | 23.32 | 16.69 | 15.97 | 20.58 | 23.23 | Upgrade
|
| EV/FCF Ratio | 28.27 | 28.07 | - | 73.03 | 31.78 | 32.15 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.06 | - | 0.18 | 0.05 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.33 | -0.30 | -0.38 | -0.52 | -0.55 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.96 | -2.96 | -1.98 | -2.49 | -3.26 | -3.52 | Upgrade
|
| Net Debt / FCF Ratio | -5.67 | -5.67 | 4.38 | -14.07 | -6.04 | -5.78 | Upgrade
|
| Asset Turnover | 0.61 | 0.61 | 0.62 | 0.66 | 0.65 | 0.63 | Upgrade
|
| Inventory Turnover | 3.45 | 3.45 | 3.37 | 3.88 | 4.51 | 4.55 | Upgrade
|
| Quick Ratio | 2.04 | 2.04 | 2.48 | 2.37 | 2.94 | 3.24 | Upgrade
|
| Current Ratio | 2.48 | 2.48 | 3.11 | 2.82 | 3.34 | 3.59 | Upgrade
|
| Return on Equity (ROE) | 1.72% | 1.72% | 4.81% | 10.10% | 10.18% | 10.43% | Upgrade
|
| Return on Assets (ROA) | 3.43% | 3.43% | 5.80% | 6.12% | 6.52% | 6.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.81% | 10.02% | 13.03% | 17.18% | 20.94% | 21.02% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.90% | 11.30% | 12.10% | 13.00% | 12.90% | Upgrade
|
| Earnings Yield | 0.87% | 0.91% | 2.17% | 4.04% | 3.08% | 2.80% | Upgrade
|
| FCF Yield | 2.95% | 3.06% | -3.20% | 1.11% | 2.64% | 2.66% | Upgrade
|
| Dividend Yield | 1.89% | - | 1.67% | 1.54% | 1.05% | 0.98% | Upgrade
|
| Payout Ratio | 209.33% | 209.33% | 74.55% | 35.52% | 32.51% | 31.71% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | -0.00% | 1.98% | 1.67% | 1.27% | 0.05% | Upgrade
|
| Total Shareholder Return | 1.89% | -0.00% | 3.65% | 3.21% | 2.32% | 1.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.